苹果酸舒尼替尼治疗晚期肾细胞癌不良反应的护理
豆艳,叶志华,刘红丽
摘要(Abstract)：
<正>晚期肾细胞癌的传统治疗方法包括生物治疗、化疗等,有效率仅15%左右。近几年靶向药物的应用,使晚期肾癌的疗效显著改善。苹果酸舒尼替尼(索坦)是一种多靶点口服靶向治疗药物,具有直接抗肿瘤作用,也有抗新生血管形成
关键词(KeyWords)： 苹果酸舒尼替尼;肾细胞癌;不良反应护理
基金项目(Foundation):
作者(Author): 豆艳,叶志华,刘红丽
参考文献(References)：
- [1]Mills EJ,Rachlis B,O'Regan C,et al.Metastatic renal cellcancer treatments:an indirect comparison meta-analysis[J].BMC Cancer,2009,27(9):34.
- [2]Castellano D,del Muro XG,Pérez-Gracia JL,et al.Patient-re-ported outcomes in a phase III,randomized study of sunitinibversus interferon-{alpha}as first-line systemic therapy for pa-tients with metastatic renal cell carcinoma in a European popu-lation[J].Ann Oncol,2009,20(11):1 803-1 812.
- [3]Wolter P,Stefan C,Decallonne B,et al.The clinical implica-tions of sunitinib-induced hypothyroidism:a prospective evalu-ation British Journal of Cancer,2008,99:448-454.
- [4]Hutson TE,Figlin RA,Kuhn JG,et al.Targeted therapiesfor metastatic renal cell carcinoma:an overview of toxicity anddosing strategies[J].Oncologist,2008,13(10):1 084-1 096.